AFMID-TMC8 Fusion FISH Probe
The AFMID-TMC8 Fusion FISH Probe is used to confirm a fusion of the AFMID and TMC8 genes. The fusion of the AFMID and TMC8 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| AFMID-TMC8-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-RERE | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-REOR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-REGO | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-REGR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-OROR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GORE | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GROR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| AFMID-TMC8-20-AQAQ | 20 (40 μL) | 200 μL |
|
AFMID Gene Summary
The Arylformamidase (AFMID) gene is located on chr17 :76183397-76203782 at 17q25.3.
Gene Name: Arylformamidase
Chromosome: CHR17: 76183397 -76203782
Locus: 17q25.3
TMC8 Gene Summary
Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 8 predicted transmembrane domains and 3 leucine zipper motifs. [provided by RefSeq, Jul 2008]
Gene Name: Transmembrane Channel Like 8
Chromosome: CHR17: 76126858 -76139049
Locus: 17q25.3
Gene Diseases
The AFMID TMC8 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|